Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anda R. F., Perlman S. B., D'Alessio D. J., Davis J. P., Dodson V. N. Hepatitis B in Wisconsin male prisoners: considerations for serologic screening and vaccination. Am J Public Health. 1985 Oct;75(10):1182–1185. doi: 10.2105/ajph.75.10.1182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chiaramonte M., Trivello R., Renzulli G., Zampieri L., Fanecco A., Floreani A., Naccarato R. Hepatitis B virus infection in prisons. A seroepidemiological survey in prisoners and attending staff. J Hyg (Lond) 1982 Aug;89(1):53–58. doi: 10.1017/s0022172400070534. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Decker M. D., Vaughn W. K., Brodie J. S., Hutcheson R. H., Jr, Schaffner W. Seroepidemiology of hepatitis B in Tennessee prisoners. J Infect Dis. 1984 Sep;150(3):450–459. doi: 10.1093/infdis/150.3.450. [DOI] [PubMed] [Google Scholar]
- Decker M. D., Vaughn W. K., Brodie J. S., Hutcheson R. H., Jr, Schaffner W. The incidence of hepatitis B in Tennessee prisoners. J Infect Dis. 1985 Jul;152(1):214–217. doi: 10.1093/infdis/152.1.214. [DOI] [PubMed] [Google Scholar]
- Hok K. A., Nieman R., Lackey J. O., Cabasso V. J. Australia antigen in a closed adult population monitored for serum glutamic oxalacetic transaminase. Appl Microbiol. 1970 Jul;20(1):6–10. doi: 10.1128/am.20.1.6-10.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hull H. F., Lyons L. H., Mann J. M., Hadler S. C., Steece R., Skeels M. R. Incidence of hepatitis B in the penitentiary of New Mexico. Am J Public Health. 1985 Oct;75(10):1213–1214. doi: 10.2105/ajph.75.10.1213. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Koplan J. P., Walker J. A., Bryan J. A., Berquist K. R. Prevalence of hepatitis B surface antigen and antibody at a state prison in Kansas. J Infect Dis. 1978 Apr;137(4):505–506. doi: 10.1093/infdis/137.4.505. [DOI] [PubMed] [Google Scholar]
- Mulley A. G., Silverstein M. D., Dienstag J. L. Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis. N Engl J Med. 1982 Sep 9;307(11):644–652. doi: 10.1056/NEJM198209093071103. [DOI] [PubMed] [Google Scholar]